Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

Fraction, PDF, Vitamin C, Anticancer, Pancreatic Cancer, Cervical Cancer, Small-Cell Lung Cancer Share and Cite: Konno, S. , Penunuri, A. , Wong, J. , Fullerton, S. and Choudhury, M. (2025) Anticancer ...

The approval allows the company to market Imfinzi 120 mg/2.4 ml and 500 mg/10 ml in combination with gemcitabine and ...

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...

The global oncology market, including breakthrough treatments, is experiencing substantial growth, with revenues projected to reach hundreds of billions of dollars in the coming years. Several factors ...

Detailed price information for Mustang Bio Inc (MBIO-Q) from The Globe and Mail including charting and trades.

Trimodal therapy improves quality of life compared with radical cystectomy in patients with muscle-invasive bladder cancer but is not cost-effective.

Unlike conventional bladder cancer, which has a consistent look under the microscope and succumbs predictably to therapy, the deadliest bladder tumors, collectively known as histologic variant (HV ...

Despite a recent rebuff from an FDA advisory committee, the first treatment for a specific and underserved cohort of U.S. bladder cancer patients has crossed the FDA finish line as UroGen Pharma ...

Even so, 30% of people with bladder cancer have no identifiable risk. Fortunately for you, a noninvasive cancer was found that was less than 3 cm, which is the best possible result for bladder cancer.

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 ...

Learn more about non-muscle invasive bladder cancer at www.BladderCancerAnswers.com. About ENVISION The Phase 3 ENVISION trial is an ongoing, single-arm, multinational, multicenter study evaluating ...